Table 1 Clinicopathological characters and PCDH10 methylation status
From: Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
PCDH10 Methylation | p value | ||
|---|---|---|---|
Yes (n = 58) | No (n = 49) | ||
Age at diagnosis | |||
<60y | 39 | 28 | 0.282 |
≥ 60y | 19 | 21 | |
Sex | |||
Male | 30 | 28 | 0.575 |
Female | 28 | 21 | |
Primary site | |||
Extranodal | 28 | 17 | 0.156 |
Nodala | 30 | 32 | |
IPI risk category | |||
Low | 26 | 22 | 0.683 |
Low-intermediate | 15 | 15 | |
High-intermediate | 13 | 7 | |
High | 4 | 5 | |
Hans Algorithm | |||
GCB | 14 | 19 | 0.102 |
Non-GCB | 44 | 30 | |
MYC FISH Breakapart | |||
No | 55 | 43 | 0.296a |
Yes | 3 | 6 | |